Abstract:Intracranial atherosclerotic stenosis (ICAS) is one of the most common causes of stroke worldwide, in particular in Chinese, Black and Hispanic populations compared with Caucasians [ 1 Wong L.K. Global burden of intracranial atherosclerosis. Int. J. Stroke. 2006; 1: 158-159 Crossref PubMed Scopus (445) Google Scholar , 2 Gorelick P.B. Wong K.S. Bae H.J. Pandey D.K. Large artery intracranial occlusive disease: a large worldwide burden but a relatively neglected frontier. Stroke. 2008; 39: 2396-2399 Crossref PubMed Scopus (518) Google Scholar ]. In addition to the medical therapy, angioplasty and stenting are alterative surgical approaches. However, recent AHA/ASA guideline on stroke prevention recommended not to adopt stenting with the Wingspan stent system as an initial treatment for patients with stroke or transient ischemic attack attributable to severe (70%–99%) ICAS (class III, level C) [ [3] Kernan W.N. Ovbiagele B. Black H.R. Bravata D.M. Chimowitz M.I. Ezekowitz M.D. et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014; 45: 2160-2236 Crossref PubMed Scopus (3181) Google Scholar ]. This recommendation was formulated based on the only randomized clinical trial — Stenting and Aggressive Medical Management for Prevention Recurrent Stroke and Intracranial Stenosis (SAMMPRIS) trial, which demonstrated that stenting had higher risk for 30-day and long-term stroke and death than aggressive medical therapy in patients with severe ICAS [ 4 Chimowitz M.I. Lynn M.J. Derdeyn C.P. Turan T.N. Fiorella D. Lane B.F. et al. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N. Engl. J. Med. 2011; 365: 993-1003 Crossref PubMed Scopus (1397) Google Scholar , 5 Derdeyn C.P. Chimowitz M.I. Lynn M.J. Fiorella D. Turan T.N. Janis L.S. et al. Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial. Lancet. 2014; 383: 333-341 Abstract Full Text Full Text PDF PubMed Scopus (576) Google Scholar ]. However, this trial was performed in Caucasians [ [4] Chimowitz M.I. Lynn M.J. Derdeyn C.P. Turan T.N. Fiorella D. Lane B.F. et al. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N. Engl. J. Med. 2011; 365: 993-1003 Crossref PubMed Scopus (1397) Google Scholar ]. Asians have more ICAS, and more diffuse lesions, whether the SAMMPRIS result validate in Chinese patients, also needs further investigation.

Translesional Pressure Gradient Alters Relationship Between Blood Pressure and Recurrent Stroke in Intracranial Stenosis.

Prevalence and Outcomes of Symptomatic Intracranial Large Artery Stenoses and Occlusions in China: the Chinese Intracranial Atherosclerosis (CICAS) Study.

Multiple predictors of in-stent restenosis after stent implantation in symptomatic intracranial atherosclerotic stenosis.

The Blood Pressure Paradox in Acute Ischemic Stroke.

Hemodynamics and stroke risk in intracranial atherosclerotic disease

Functional Evaluation of Intracranial Atherosclerotic Stenosis by Pressure Ratio Measurements

Abstract TP299: The Relationship Between Intracranial Arterial Stenosis Rate and Cerebral Perfusion

Correlations between intravascular pressure gradients and cerebral blood flow in patients with symptomatic, medically refractory, anterior circulation artery stenosis: an exploratory study

Clinical implications of haemodynamics in symptomatic intracranial atherosclerotic stenosis by computational fluid dynamics modelling: a systematic review

Risk stratification in symptomatic intracranial atherosclerotic disease with conventional vascular risk factors and cerebral haemodynamics

Factors Influencing the Outcome of Symptomatic Intracranial Artery Stenosis With Hemodynamic Impairment After Short and Long-Term Stent Placement

Hemodynamic Impairment of Blood Pressure and Stroke Mechanisms in Symptomatic Intracranial Atherosclerotic Stenosis

The Safety and Long-Term Outcomes of Angioplasty and Stenting in Symptomatic Intracranial Atherosclerotic Stenosis

Intracranial Atherosclerosis: A Disease of Functional, not Anatomic Stenosis? How Trans-Stenotic Pressure Gradients Can Help Guide Treatment

Comparison of Newtonian and Non-newtonian Fluid Models in Blood Flow Simulation in Patients With Intracranial Arterial Stenosis

Hemodynamic Markers in the Anterior Circulation as Predictors of Recurrent Stroke in Patients With Intracranial Stenosis

Cerebral hemodynamics and stroke risks in symptomatic intracranial atherosclerotic stenosis with internal versus cortical borderzone infarcts: A computational fluid dynamics study

Concomitant Asymptomatic Intracranial Atherosclerotic Stenosis Increase the 30-Day Risk of Stroke in Patients Undergoing Symptomatic Intracranial Atherosclerotic Stenosis Stenting

Optimal Medical Management of Atherosclerotic Intracranial Stenosis

Stenting versus medical treatment alone for symptomatic intracranial artery stenosis: a preplanned pooled individual patient data analysis

Residual inflammatory risk predicts long-term outcomes following stenting for symptomatic intracranial atherosclerotic stenosis